Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Apply
Atezolizumab with Chemotherapy
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step